Syra Health Corp. Class A Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Syra Health Corp. Class A Common Stock generated cash of -$2,759,068, which is less than the previous year. Cash used in financing activities reached the amount of $6,051,050 last year. Net change in cash is therefore $3,276,731.
Cash Flow
| 2022 | -2.24M | -121.26K | 2.26M |
|---|---|---|---|
| 2023 | -2.75M | -15.25K | 6.05M |
SYRA Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 3.34K | 100.01K |
Operating activities | ||
Net income | -2.93M | -2.11M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 48.77K | 14.84K |
Stock-based compensation expense | 32.83K | 2.91K |
| Deferred income tax benefit | 32.83K | 2.91K |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -110.16K | -940.47K |
Inventories | 0 | 0 |
Accounts payable | 27.40K | 309.85K |
Cash generated by operating activities | -2.75M | -2.24M |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -15.25K | -121.26K |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -15.25K | -121.26K |
Financing activities | ||
Common Stock Issued | 5.33M | 2.32M |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 718.76K | 736.47K |
Cash used in financing activities | 6.05M | 2.26M |
Net Change In Cash | 3.27M | -96.66K |
Cash at end of period | 3.28M | 3.34K |
| Data source |